HANDLING OF DIGOXIN AND OUABAIN BY RENAL TUBULAR CELLS (LLC-PK1)

被引:0
|
作者
ITO, S
KOREN, G
HARPER, PA
机构
来源
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 1992年 / 262卷 / 01期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Digoxin is known to be secreted by renal tubular cells, but the mechanisms are still not fully understood. In this study, we examined renal tubular cell handling of digoxin and ouabain using LLC-PK1 cells, a model of proximal renal tubular cells. The cells were used in suspension for binding experiments and in monolayers on permeable filters for transport studies. The specific binding of digoxin to the cells, presumably to the ouabain binding site (i.e., membrane Na+, K+-ATPase), were characterized by K(d) of 2.6 x 10(-7) M and B(max) (total number of specific binding sites) of 1.6 x 10(6)/cell. K(d) and B(max) of ouabain binding were 1.3 x 10(-7) M and 1.9 x 10(6)/cell, respectively. In transport experiments, digoxin showed significantly higher flux than ouabain from the basolateral to the apical side across the cell monolayers. Importantly, this secretory transport was not inhibited by ouabain concentrations sufficient to block membrane Na+,K+-ATPase and to displace digoxin from the binding site on the enzyme (i.e., 10(-6) to 10(-4) M ouabain). However, the digoxin secretion was decreased by low temperature or excess digoxin in a concentration-dependent manner. These data suggest that digoxin undergoes unidirectional transport in favor of secretion, which does not involve its binding to the ouabain binding sites on membrane Na+,K+-ATPase.
引用
收藏
页码:109 / 113
页数:5
相关论文
共 50 条
  • [31] Regulation of TauT by cisplatin in LLC-PK1 renal
    Han, XB
    Chesney, RW
    PEDIATRIC RESEARCH, 2004, 55 (04) : 575A - 575A
  • [32] UPTAKE OF PUTRESCINE INTO CULTURED RENAL EPITHELIAL-CELLS, LLC-PK1
    HAUSER, M
    COOK, JS
    FASEB JOURNAL, 1988, 2 (04): : A751 - A751
  • [33] Cellular uptake properties of oligonucleotides in LLC-PK1 renal epithelial cells
    Takakura, Y
    Oka, Y
    Hashida, M
    ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1998, 8 (01): : 67 - 73
  • [34] LLC-PK1 cells as a model for renal toxicity caused by arsine exposure
    Ayala-Fierro, F
    Carter, DE
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, 2000, 60 (01): : 67 - 79
  • [35] Characterization of LLC-PK1 kidney epithelial cells as an in vitro model for studying renal tubular reabsorption of protein drugs
    Takakura, Y
    Morita, T
    Fujikawa, M
    Hayashi, M
    Sezaki, H
    Hashida, M
    Borchardt, RT
    PHARMACEUTICAL RESEARCH, 1995, 12 (12) : 1968 - 1972
  • [36] Inhibition of oxidant-induced lipid peroxidation in cultured renal tubular epithelial cells (LLC-PK1) by quercetin
    Kuhlmann, MK
    Burkhardt, G
    Horsch, E
    Wagner, M
    Köhler, H
    FREE RADICAL RESEARCH, 1998, 29 (05) : 451 - 460
  • [37] MODULATION OF THE OCCLUDING JUNCTIONS IN AN EPITHELIAL-CELL LINE (LLC-PK1) WITH CHARACTERISTICS OF RENAL PROXIMAL TUBULAR CELLS
    RABITO, CA
    FEDERATION PROCEEDINGS, 1985, 44 (03) : 443 - 443
  • [38] Handling of doxorubicin by the LLC-PK1 kidney epithelial cell line
    Decorti, G
    Peloso, I
    Favarin, D
    Klugmann, FB
    Candussio, L
    Crivellato, E
    Mallardi, F
    Baldini, L
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1998, 286 (01): : 525 - 530
  • [39] DOPAMINE SYNTHESIS AND RELEASE IN LLC-PK1 CELLS
    DAWSON, R
    PHILLIPS, MI
    EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1990, 189 (06): : 423 - 426
  • [40] CYTOTOXICITY OF MERCURY-COMPOUNDS IN LLC-PK1, MDCK AND HUMAN PROXIMAL TUBULAR CELLS
    BOHETS, HH
    VANTHIELEN, MN
    VANDERBIEST, I
    VANLANDEGHEM, GF
    DHAESE, PC
    NOUWEN, EJ
    DEBROE, ME
    DIERICKX, PJ
    KIDNEY INTERNATIONAL, 1995, 47 (02) : 395 - 403